The Proof Is In The Patient

We are committed to developing best-in-class evidence to improve treatment and support patient access. Our evidence portfolio advances the use of spinal cord stimulation for pain areas commonly treated with SCS and represents continued investment in industry-first trials such as painful diabetic neuropathy (PDN)* and non-surgical refractory back pain (NSRBP).

Landmark Publications

Nevro aims to develop and publish rigorous evidence to support critical decisions made by physicians, regulators and payors.